Product Overview

KLOW combines four research peptides in one lyophilized vial: KPV, GHK-Cu, BPC-157, and TB-500. Each has been studied for a different type of signaling activity.

• KPV is a tripeptide fragment of α-MSH, studied for inflammatory pathway activity.
• GHK-Cu is a copper-binding tripeptide, examined for its role in extracellular matrix and tissue-remodeling signaling.
• BPC-157 has been studied for angiogenic and cytoprotective activity.
• TB-500 has been researched for actin regulation and cell migration.

In controlled laboratory settings, the blend is used to study the combined receptor and signaling-pathway activity of all four components. It is relevant to inflammation and tissue-remodeling research.

Important Note

This blend is not approved for human consumption, medical or veterinary use, or diagnostic purposes. It is supplied for laboratory research only and should be handled by qualified professionals in a controlled research setting.

Specifications

Specification	Detail
Composition	GHK-Cu, BPC-157, TB-500, KPV
Vial Content (labeled)	80mg total blend
Measured Content	GHK-Cu 40.06 mg (GHK 35.45 mg, Cu 4.61 mg); BPC-157 10.86 mg; TB-500 9.79 mg; KPV 10.31 mg
Form	Lyophilized powder
Storage	Store below –20°C. Keep away from light.
Vial	Clear borosilicate glass, butyl rubber stopper, aluminum crimp closure
Purity	99%+ (HPLC-UV)
Lot Number	TCG-KLW-20260723
Test Date	06 Aug 2026
Testing Lab	Janoshik
Lab Report	Janoshik #211882 (Verification Key: 5B44HTIK6AR1)
Heavy Metals Report	Janoshik #211885

Features & Properties

• Four peptides in one fixed-ratio vial: KPV, GHK-Cu, BPC-157, and TB-500
• KPV (α-MSH fragment) studied for inflammatory pathway activity
• GHK-Cu examined for extracellular matrix and tissue-remodeling signaling
• BPC-157 studied for angiogenic and cytoprotective activity
• TB-500 researched for actin regulation and cell migration
• Supplied as a lyophilized powder for stability during storage and transport

Storage & Stability

• Store the lyophilized powder at –20°C, where it remains stable for up to 24 months
• Avoid repeated freeze–thaw cycles
• Protect from light and moisture at all times

Usage Restrictions

• For laboratory research use only
• Not approved for human consumption, medical or veterinary use, or diagnostic purposes
• Handling should be carried out by qualified professionals in controlled research settings
• Store securely and keep out of reach of children
• Do not handle during pregnancy or breastfeeding

Frequently Asked Questions

Q1. What does each vial contain?
Each vial is labeled as an 80mg blend of GHK-Cu, KPV, BPC-157, and TB-500 in sterile lyophilized powder form. The Janoshik test for this lot measured GHK-Cu at 40.06 mg, BPC-157 at 10.86 mg, TB-500 at 9.79 mg, and KPV at 10.31 mg.

Q2. What does the product look like?
A fine white to off-white powder at the base of the vial. It may have a faint blue tint from the copper peptide.

Q3. How should it be stored?
Keep it at –20°C, away from light and moisture. Stored this way, it remains stable for up to 24 months.

Q4. Is it sterile?
It is manufactured and sealed under sterile laboratory conditions. Standard sterile handling still applies in the lab.

Q5. Is this product for human use?
No. It is intended for laboratory research only and is not approved for medical or veterinary use.

Q6. Has this lot been third-party tested?
Yes. This lot was tested by Janoshik on 06 Aug 2026 (Report #211882), with purity listed at 99%+ (HPLC-UV). A separate heavy metals analysis is also available (Report #211885). Both reports can be viewed through the COA / Testing links on this page.

Q7. What is the vial packaging?
A clear borosilicate glass vial sealed with a butyl rubber stopper and an aluminum crimp closure.

Q8. Is the product stable during shipping?
The lyophilized form holds up under standard shipping conditions. Move it to –20°C storage as soon as it arrives.

Q9. Who can handle this product?
Only qualified laboratory researchers trained in peptide handling and using proper protective equipment.